Takeda Pharmaceutical (TAK) |
Japan |
$63.153B |
9.98 |
Zoetis (ZTS) |
United States |
$57.975B |
34.68 |
Astellas Pharma (ALPMY) |
Japan |
$32.884B |
16.42 |
Eisai (ESALY) |
Japan |
$21.873B |
42.18 |
Grifols, S.A (GRFS) |
Spain |
$15.793B |
20.69 |
UCB SA (UCBJF) |
Belgium |
$15.697B |
0.00 |
Merck (MKGAF) |
Germany |
$14.809B |
20.21 |
Neurocrine Biosciences (NBIX) |
United States |
$10.757B |
507.87 |
Ono Pharmaceutical (OPHLF) |
Japan |
$9.450B |
20.20 |
Ionis Pharmaceuticals (IONS) |
United States |
$9.088B |
18.41 |
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) |
Italy |
$8.638B |
0.00 |
Jazz Pharmaceuticals (JAZZ) |
Ireland |
$8.455B |
10.80 |
IPSEN SA ADR (IPSEY) |
France |
$7.796B |
0.00 |
Catalent (CTLT) |
United States |
$7.615B |
30.98 |
Arrowhead Pharmaceuticals (ARWR) |
United States |
$6.438B |
97.49 |
Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$6.263B |
0.00 |
Orion OYJ (ORINY) |
Finland |
$5.849B |
30.12 |
STADA ARZNEIMI (STDAF) |
Germany |
$5.375B |
0.00 |
Hypermarcas (HYPMY) |
Brazil |
$4.698B |
16.89 |
FibroGen (FGEN) |
United States |
$4.135B |
121.51 |
United Therapeutics (UTHR) |
United States |
$4.020B |
0.00 |
Taro Pharmaceutical Industries (TARO) |
Israel |
$3.774B |
13.79 |
Nektar Therapeutics (NKTR) |
United States |
$3.598B |
0.00 |
Sage Therapeutics (SAGE) |
United States |
$3.340B |
0.00 |
Evotec AG (EVTCY) |
Germany |
$3.326B |
54.42 |
PTC Therapeutics (PTCT) |
United States |
$3.032B |
0.00 |
Xencor (XNCR) |
United States |
$2.329B |
70.79 |
Heron Therapeutics (HRTX) |
United States |
$2.318B |
0.00 |
Portola Pharmaceuticals (PTLA) |
United States |
$2.273B |
0.00 |
Zogenix (ZGNX) |
United States |
$2.074B |
0.00 |
Ironwood Pharmaceuticals (IRWD) |
United States |
$1.957B |
62.40 |
Pacira Pharmaceuticals (PCRX) |
United States |
$1.914B |
56.63 |
Tilray (TLRY) |
Canada |
$1.829B |
0.00 |
ChemoCentryx (CCXI) |
United States |
$1.816B |
0.00 |
USANA Health Sciences (USNA) |
United States |
$1.652B |
17.63 |
Corcept Therapeutics (CORT) |
United States |
$1.520B |
18.47 |
Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.456B |
0.00 |
Enanta Pharmaceuticals (ENTA) |
United States |
$1.264B |
28.86 |
CLINIGEN GP (CLIGF) |
United Kingdom |
$1.244B |
0.00 |
Theravance Biopharma (TBPH) |
Cayman Islands |
$1.197B |
0.00 |
ArQule (ARQL) |
United States |
$1.167B |
0.00 |
Spectrum Pharmaceuticals (SPPI) |
United States |
$1.112B |
0.00 |
AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$1.101B |
7.51 |
Endo (ENDP) |
Ireland |
$1.098B |
2.02 |
Karyopharm Therapeutics (KPTI) |
United States |
$1.023B |
0.00 |
Radius Health (RDUS) |
United States |
$1.012B |
0.00 |
Aerie Pharmaceuticals (AERI) |
United States |
$0.920B |
0.00 |
Flexion Therapeutics (FLXN) |
United States |
$0.746B |
0.00 |
Collegium Pharmaceutical (COLL) |
United States |
$0.706B |
0.00 |
Akebia Therapeutics (AKBA) |
United States |
$0.703B |
0.00 |
TherapeuticsMD (TXMD) |
United States |
$0.659B |
0.00 |
Translate Bio (TBIO) |
United States |
$0.600B |
0.00 |
ImmunoGen (IMGN) |
United States |
$0.579B |
0.00 |
Crinetics Pharmaceuticals (CRNX) |
United States |
$0.493B |
0.00 |
Organogenesis Holdings (ORGO) |
United States |
$0.484B |
0.00 |
Catalyst Pharmaceuticals (CPRX) |
United States |
$0.481B |
58.38 |
Harpoon Therapeutics (HARP) |
United States |
$0.466B |
0.00 |
Molecular Templates (MTEM) |
United States |
$0.452B |
0.00 |
Aptorum Group (APM) |
Hong Kong, SAR China |
$0.440B |
0.00 |
Ardelyx (ARDX) |
United States |
$0.430B |
0.00 |
Dermira (DERM) |
United States |
$0.430B |
0.00 |
BioSpecifics Technologies Corp (BSTC) |
United States |
$0.406B |
17.52 |
BioCryst Pharmaceuticals (BCRX) |
United States |
$0.396B |
0.00 |
Indivior (INVVY) |
United States |
$0.385B |
1.39 |
DURECT (DRRX) |
United States |
$0.377B |
0.00 |
Recro Pharma (REPH) |
United States |
$0.375B |
0.00 |
Rigel Pharmaceuticals (RIGL) |
United States |
$0.364B |
0.00 |
Siga Technologies (SIGA) |
United States |
$0.359B |
8.20 |
Innate Pharma SA (IPHYF) |
France |
$0.358B |
0.00 |
Lannett Co Inc (LCI) |
United States |
$0.355B |
4.13 |
OptiNose (OPTN) |
United States |
$0.352B |
0.00 |
Concordia (CXRXF) |
Canada |
$0.333B |
0.00 |
Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.332B |
0.00 |
Rafael Holdings (RFL) |
United States |
$0.318B |
0.00 |
Matinas Biopharma Holdings (MTNB) |
United States |
$0.312B |
0.00 |
GlycoMimetics (GLYC) |
United States |
$0.260B |
0.00 |
Jounce Therapeutics (JNCE) |
United States |
$0.259B |
3.46 |
KalVista Pharmaceuticals (KALV) |
United States |
$0.256B |
0.00 |
Calithera Biosciences (CALA) |
United States |
$0.252B |
0.00 |
Xeris Pharmaceuticals (XERS) |
United States |
$0.236B |
0.00 |
Avadel Pharmaceuticals (AVDL) |
Ireland |
$0.236B |
0.00 |
Ocular Therapeutix (OCUL) |
United States |
$0.210B |
0.00 |
Aquestive Therapeutics (AQST) |
United States |
$0.201B |
0.00 |
Nature's Sunshine Products (NATR) |
United States |
$0.189B |
32.57 |
Foamix Pharmaceuticals (FOMX) |
Israel |
$0.187B |
0.00 |
Concert Pharmaceuticals (CNCE) |
United States |
$0.175B |
0.00 |
Taiwan Liposome (TLC) |
Taiwan |
$0.161B |
0.00 |
AcelRx Pharmaceuticals (ACRX) |
United States |
$0.149B |
0.00 |
MEI Pharma (MEIP) |
United States |
$0.144B |
0.00 |
Redhill Biopharma (RDHL) |
Israel |
$0.144B |
0.00 |
IMV INC (IMV) |
Canada |
$0.143B |
0.00 |
MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.141B |
0.00 |
Galmed Pharmaceuticals (GLMD) |
Israel |
$0.137B |
0.00 |
CannTrust Holdings (CTST) |
Canada |
$0.119B |
0.00 |
ALLERGY THERAPT (AGYTF) |
United Kingdom |
$0.108B |
0.00 |
Champions Oncology (CSBR) |
United States |
$0.091B |
0.00 |
La Jolla Pharmaceutical (LJPC) |
United States |
$0.089B |
0.00 |
CV Sciences (CVSI) |
United States |
$0.085B |
0.00 |
Cumberland Pharmaceuticals (CPIX) |
United States |
$0.078B |
23.45 |
MediWound (MDWD) |
Israel |
$0.078B |
0.00 |
Otonomy (OTIC) |
United States |
$0.077B |
0.00 |
PolarityTE (PTE) |
United States |
$0.076B |
0.00 |
Neos Therapeutics (NEOS) |
United States |
$0.073B |
0.00 |
Infinity Pharmaceuticals (INFI) |
United States |
$0.071B |
0.00 |
Capnia (SLNO) |
United States |
$0.070B |
0.00 |
Aclaris Therapeutics (ACRS) |
United States |
$0.069B |
0.00 |
Cardiome Pharma (CORV) |
Canada |
$0.066B |
0.00 |
Pharmaxis (PXSLY) |
Australia |
$0.065B |
0.00 |
Entasis Therapeutics Holdings (ETTX) |
United States |
$0.065B |
0.00 |
RENEURON GP (RNUGF) |
United Kingdom |
$0.062B |
0.00 |
ASSERTIO THERAPEUTICS, INC (ASRT) |
United States |
$0.058B |
0.00 |
Novan (NOVN) |
United States |
$0.057B |
0.00 |
Nivalis Therapeutics (ALPN) |
United States |
$0.057B |
0.00 |
SCYNEXIS (SCYX) |
United States |
$0.056B |
0.00 |
Opiant Pharmaceuticals (OPNT) |
United States |
$0.055B |
0.00 |
Natural Alternatives (NAII) |
United States |
$0.055B |
13.73 |
CTI BioPharma (CTIC) |
United States |
$0.054B |
0.00 |
Medicure (MCUJF) |
Canada |
$0.054B |
0.00 |
IntelGenx Technologies (IGXT) |
Canada |
$0.051B |
0.00 |
Summit Therapeutics (SMMT) |
United Kingdom |
$0.049B |
0.00 |
ElectroCore (ECOR) |
United States |
$0.049B |
0.00 |
AgeX Therapeutics (AGE) |
United States |
$0.047B |
0.00 |
Mast Therapeutics (SVRA) |
United States |
$0.046B |
0.00 |
Iterum Therapeutics (ITRM) |
Ireland |
$0.046B |
0.00 |
Dipexium Pharmaceuticals (PLXP) |
United States |
$0.041B |
0.00 |
Bellicum Pharmaceuticals (BLCM) |
United States |
$0.040B |
0.00 |
IsoRay (ISR) |
United States |
$0.040B |
0.00 |
Mannatechorporated (MTEX) |
United States |
$0.038B |
0.00 |
Opexa Therapeutics (ACER) |
United States |
$0.037B |
0.00 |
Adamis Pharmaceuticals (ADMP) |
United States |
$0.034B |
0.00 |
Jaguar Animal Health (JAGX) |
United States |
$0.030B |
0.00 |
PharmAthene (ALT) |
United States |
$0.029B |
0.00 |
India Globalization Capital (IGC) |
United States |
$0.028B |
0.00 |
Biomerica (BMRA) |
United States |
$0.028B |
0.00 |
Eyegate Pharmaceuticals (EYEG) |
United States |
$0.025B |
0.00 |
ProPhase Labs (PRPH) |
United States |
$0.024B |
0.00 |
Melinta Therapeutics (MLNT) |
United States |
$0.024B |
0.00 |
Bio-Path Holdings (BPTH) |
United States |
$0.023B |
0.00 |
Shineco (TYHT) |
China |
$0.021B |
0.00 |
China SXT Pharmaceuticals (SXTC) |
China |
$0.020B |
0.00 |
NovaBay Pharmaceuticals (NBY) |
United States |
$0.016B |
0.00 |
Regulus Therapeutics (RGLS) |
United States |
$0.016B |
0.00 |
Flex Pharma (SLRX) |
United States |
$0.016B |
0.00 |
Vical (BBI) |
United States |
$0.016B |
0.00 |
Heat Biologics (HTBX) |
United States |
$0.015B |
0.00 |
VAXART, INC (VXRT) |
United States |
$0.015B |
0.00 |
Kitov Pharmaceuticals Holdings (KTOV) |
Israel |
$0.014B |
0.00 |
Cyanotech (CYAN) |
United States |
$0.014B |
0.00 |
Lipocine (LPCN) |
United States |
$0.010B |
0.00 |
HANCOCK JAFFE (HJLI) |
United States |
$0.009B |
0.00 |
Achieve Life Sciences (ACHV) |
United States |
$0.008B |
0.00 |
Tetraphase Pharmaceuticals (TTPH) |
United States |
$0.007B |
0.00 |
Sonoma Pharmaceuticals (SNOA) |
United States |
$0.005B |
0.00 |
RXi Pharmaceuticals (PHIO) |
United States |
$0.005B |
0.00 |
Xenetic Biosciences (XBIO) |
United States |
$0.005B |
0.00 |
Can-Fite Biopharma (CANF) |
Israel |
$0.005B |
0.00 |
Hemispherx BioPharma (AIM) |
United States |
$0.003B |
0.00 |
Onconova Therapeutics (ONTX) |
United States |
$0.002B |
0.00 |
Midatech Pharma (MTP) |
United Kingdom |
$0.002B |
0.00 |
Cytori Therapeutics Inc (PSTV) |
United States |
$0.001B |
0.00 |
Advanced Accelerator Applications S.A (AAAP) |
France |
$0.000B |
0.00 |
Forward Pharma (FWP) |
Denmark |
$0.000B |
0.00 |